Lertsuphotvanit Nutdanai, Sirirak Jitnapa, Tamdee Poomipat, Tuntarawongsa Sarun, Phaechamud Thawatchai, Chantadee Takron
Program of Pharmaceutical Technology, Faculty of Pharmacy, Silpakorn University, Nakhon Pathom 73000, Thailand.
Department of Chemistry, Faculty of Science, Silpakorn University, Nakhon Pathom 73000, Thailand.
Pharmaceutics. 2023 Jul 31;15(8):2053. doi: 10.3390/pharmaceutics15082053.
As an alternative to the traditional polymeric-based system, it is now possible to use an in situ forming system that is based on small molecules. Borneol was used as matrix formation in this study. While triacetin was incorporated into the formulation for prolonging the drug release. The objective of this study is to understand the initial period of the solvent exchange mechanism at the molecular level, which would provide a basis for explaining the matrix formation and drug release phenomena. The evaluation of basic physical properties, matrix formation, in vitro drug release, and molecular dynamics (MD) simulation of borneol-based in situ forming matrixes (ISM) was conducted in this study. The proportion of triacetin was found to determine the increase in density and viscosity. The density value was found to be related to viscosity which could be used for the purpose of prediction. Slow self-assembly of ISM upon the addition of triacetin was associated with higher viscosity and lower surface tension. This phenomenon enabled the regulation of solvent exchange and led to sustaining the drug release. In MD simulation using AMBER Tools, the free movement of the drug and the rapid approach to equilibrium of both solvent and water molecule in a solvent exchange mechanism in borneol-free ISM was observed, supporting that sustained release would not occur. Water infiltration was slowed down and NMP movement was restricted by the addition of borneol and triacetin. In addition, the increased proportion of triacetin promoted the diminished down of all substances' movement because of the viscosity. The diffusion constant of relevant molecules decreased with the addition of borneol and/or triacetin. Although the addition of triacetin tended to slow down the solvent exchange and molecular movement from computation modelling results, it may not guarantee to imply the best drug release control. The Low triacetin-incorporated (5%) borneol-based ISM showed the highest ability to sustain the drug release due to its self-assembly and has proper solvent exchange. MD simulation addressed the details of the mechanism at the beginning of the process. Therefore, both MD and classical methods contribute to a clearer understanding of solvent exchange from the molecular to macroscopic level and from the first nanosecond of the formulation contact with water to the 10-day of drug release. These would be beneficial for subsequent research and development efforts in small molecule-based in situ forming systems.
作为传统聚合物基体系的替代方案,现在可以使用基于小分子的原位形成体系。在本研究中,冰片用作基质形成材料。同时,将三醋精加入制剂中以延长药物释放。本研究的目的是在分子水平上理解溶剂交换机制的初始阶段,这将为解释基质形成和药物释放现象提供依据。本研究对基于冰片的原位形成基质(ISM)的基本物理性质、基质形成、体外药物释放和分子动力学(MD)模拟进行了评估。发现三醋精的比例决定了密度和粘度的增加。发现密度值与粘度相关,可用于预测目的。加入三醋精后ISM的缓慢自组装与较高的粘度和较低的表面张力有关。这种现象能够调节溶剂交换并导致药物释放的持续。在使用AMBER工具的MD模拟中,观察到在无冰片的ISM的溶剂交换机制中药物的自由移动以及溶剂和水分子快速达到平衡,这支持不会发生持续释放。加入冰片和三醋精减缓了水的渗透并限制了NMP的移动。此外,由于粘度,三醋精比例的增加促进了所有物质移动的减弱。相关分子的扩散常数随着冰片和/或三醋精的加入而降低。尽管从计算建模结果来看,加入三醋精倾向于减缓溶剂交换和分子移动,但这可能并不保证意味着最佳的药物释放控制。低三醋精含量(5%)的基于冰片的ISM由于其自组装且具有适当的溶剂交换,显示出最高的持续药物释放能力。MD模拟揭示了该过程开始时机制的细节。因此,MD和经典方法都有助于从分子到宏观层面以及从制剂与水接触的第一纳秒到药物释放的10天更清楚地理解溶剂交换。这些将有利于基于小分子的原位形成体系的后续研发工作。